Purpose. To evaluate the features of the development of arterial hypertension in people with metabolic syndrome and to justify preventive measures.
Object and research methods. 92 adult patients aged 40 to 49 years were examined, among them 73 women and 19 men. The survey was conducted among respondents using a questionnaire.
General clinical indicators were recorded: determination of height, weight with subsequent calculation of body mass index (kg\m2), waist circumference, systolic and diastolic blood pressure. Among the laboratory indicators, the following results attracted attention: glucose, insulin, Homa index, leptin, creatinine, cystatin-c, glomerular filtration rate (GFR). Statistical processing of the results was carried out with the help of correlation analysis, definition of criteria of differences, graphic methods. Statistical processing of the results was carried out with the help of correlation analysis, definition of criteria of differences, graphic methods.
During the research, the author adhered to the principles of bioethics and the Order of the Ministry of Health of Ukraine "On the approval of the Procedure for conducting clinical trials and the Standard Regulations on the Commission on Ethics No. 66 dated February 13, 2006, with amendments of 2006-2008. All patients signed an informed consent to participate in the study.
Research results and their discussion. A register of respondents was created - adult men and women who were under the influence of a modified factor - overweight or obesity, which is a trigger for the prevalence of such conditions as insulin resistance, leptin resistance, arterial hypertension. The research found that 73% of the examined were overweight or obese. A reliable relationship between quantitative indicators was also confirmed using Pearson's correlation analysis (r) between waist circumference and age (r=0.55, p<0.002), height (r=0.547, p<0.002), weight (r=0.547, p<0.002), BMI (r=0.753, p<0.001), creatinine (r=0.548, p<0.002). This once again confirms that waist circumference increases with age, height, weight, body mass index, and the increase in creatinine depends on waist circumference and height (r=0.364, p<0.048). Thanks to the analysis of variance, reliable relationships were found between quantitative and rank indicators: Homa's index and sport (F=1.809, P=0.049), as well as leptin and sport (F=1.809, P=0.049), leptin and weight (F=0.644, P=0.035).
Conclusions. An in- depth comprehensive examination with the simultaneous determination of anthropometric, hemodynamic, and hormonal indicators of the state of health made it possible to justify preventive measures against metabolic syndrome.
It was shown that 73.0% of respondents were overweight and obese, which can be considered a risk factor for the development of arterial hypertension. A reliable relationship between quantitative indicators was established using Pearson's correlation analysis (r) between waist circumference and age, height, weight, BMI, creatinine. It was determined that cystatin – c is negatively correlated with the rate of glomerular filtration in the absence of an increase in creatinine.
People with metabolic syndrome (both men and women) are recommended to take preventive measures to prevent the development of complications of arterial hypertension.

Body mass index, arterial hypertension, metabolic syndrome.

1. Abete I, Goyenechea E, Zulet MA, Martínez JA. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis. 2011 Sep;21;2:B1-B15. doi: https://doi.org/10.1016/j.numecd.2011.05.001

2. Patrão AL, Almeida MDC, Matos SMA, Chor D, Aquino EML. Gender and psychosocial factors associated with healthy lifestyle in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) cohort: a cross-sectional study. BMJ Open. 2017 Aug 28;7(8):e015705. doi: https://doi.org/10.1136/bmjopen-2016-015705

3. Gaw³owska B, Chaw³owska E. An Assessment of Health Behaviours in Primary Care Patients: A Cross-Sectional Study. Healthcare (Basel). 2024 Jul 15;12(14):1405. doi: https://doi.org/10.3390/healthcare12141405

4. Miranda JJ, Barrientos-Gutiérrez T, Corvalan C, Hyder AA, Lazo-Porras M, Oni T, Wells JCK. Understanding the rise of cardiometabolic diseases in low- and middle-income countries. Nat Med. 2019 Nov;25(11):1667-79. doi: https://doi.org/10.1038/s41591-019-0644-7

5. Paula DP, Camacho M, Barbosa O, Marques L, Harter Griep R, da Fonseca MJM, Barreto S, Lekadir K. Sex and population differences in the cardiometabolic continuum: a machine learning study using the UK Biobank and ELSA-Brasil cohorts. BMC Public Health. 2024 Aug 6;24(1):2131. doi: https://doi.org/10.1186/s12889-024-19395-9

6. Litwin M, Ku³aga Z. Obesity, metabolic syndrome, and primary hypertension. Pediatr Nephrol. 2021 Apr;36(4):825-37. doi: https://doi.org/10.1007/s00467-020-04579-3

7. Weihe P, Weihrauch-Blüher S. Metabolic Syndrome in Children and Adolescents: Diagnostic Criteria, Therapeutic Options and Perspectives. Curr Obes Rep. 2019 Dec;8(4):472-9. doi: https://doi.org/10.1007/s13679-019-00357-x

8. Bussler S, Penke M, Flemming G, Elhassan YS, Kratzsch J, Sergeyev E, Lipek T, Vogel M, Spielau U, Körner A, de Giorgis T, Kiess W. Novel Insights in the Metabolic Syndrome in Childhood and Adolescence. Horm Res Paediatr. 2017;88(3-4):181-93. doi: https://doi.org/10.1159/000479510

9. Morella IM, Brambilla R, Morè L. Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders. Neurosci Biobehav Rev. 2022 Nov;142:104892. doi: https://doi.org/10.1016/j.neubiorev.2022.104892

Mykhaylenko OYu. [Prevention of arterial hypertension as a component of the metabolic syndrome]. Hygiene of Populated Places. 2024;74:172-179.